In the case of IDH mutations in astrocytoma and oligodendroglioma, proof of concept in radiomics has already been demonstrated [95], but will be more challenging for glioblastoma, which by definition is IDH wildtype. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).